Comparative study of micro‐transplantation from HLA fully mismatched unrelated and partly matched related donors in acute myeloid leukemia

Autor: Zheng Dong, Bo Cai, Kai-Xun Hu, Hong-Li Zuo, Jian-Hui Qiao, Chang-Lin Yu, Mei Guo, Yi Wang, Xin Du, Ya-Jing Huang, Qi-Yun Sun, Hui-Sheng Ai
Rok vydání: 2020
Předmět:
Zdroj: American Journal of Hematology. 95:630-636
ISSN: 1096-8652
0361-8609
DOI: 10.1002/ajh.25780
Popis: Micro-transplantation (MST) by chemotherapy, combined with granulocyte colony-stimulating factor-mobilized peripheral blood stem cell (GPBSC) infusion, from an HLA partial matched related donor has shown some encouraging effective therapy for acute myeloid leukemia (AML). However, the outcome of human leukocyte antigen (HLA) fully mismatched unrelated donor-derived MST in such patients is still unknown. In the present study, we compared the efficacy of HLA fully mismatched unrelated donor-derived MST, and partly matched related donor-derived MST, in AML of 126 patients from two centers in China, These patients, aged 16 to 65 years, were given three or four courses of MST, which consisted of a high dosage cytarabine followed by GPBSC from unrelated donor or related donor. There was a statistically significant difference in 3-year leukemia-free survival (LFS) and 3-year overall survival (OS) between the unrelated and the related group. The non-treatment-related mortality (NRM) rates of patients, and other adverse complications, were no different in the two groups. In conclusion, unrelated donor-derived MST is believed to be a safe treatment, with efficacy similar to or higher than related donor-derived MST. This result provides support for the potential of MST for expanding the donor selection. However, the specific mechanism of action needs further study.
Databáze: OpenAIRE
Externí odkaz: